Clinical Trials

The main objective of this study is to test whether individuals with schizophrenia spectrum disorders exhibit quantifiable abnormalities in transcranial magnetic stimulation (TMS) evoked electroencephalographic (EEG) potentials (TEPs); and whether social and non-social cognitive performance in patients with schizophrenia spectrum disorders are correlated with TEP abnormalities.

The purpose of this study is to find out if some patients with mood symptoms have antibodies (part of the immune system) that affect the brain, and could possibly play a role in the development of mood symptoms. We also want to find out if these immune markers change once your mood normalizes.

The FLAME Study is a 16-week clinical trial to study treatment with lamotrigine or fluoxetine in bipolar I, II and bipolar schizoaffective depressed adults. The purpose of the trial is to have a better understanding of whether individuals with a particular gene type and other inherited biological markers will have a good response to fluoxetine or lamotrigine, or alternatively, would be more likely to have side effects to this medication.

The purpose of this study is to evaluate the clinical and neurocognitive correlates of COVID-19 in patients with bipolar disorder (BD).